Physician profile
Nilay K Patel
NPI 1013279454
$50,490.88
in general payments reported to CMS, 2019-2025
14 companies · $5,280 in 2025
The $5,280 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $18K · 2021: $321 · 2022: $12K · 2023: $238 · 2024: $14K · 2025: $5,280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Travel and Lodging: $3,778 · Food and Beverage: $1,491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,395.00 |
| Travel and Lodging | $3,778.37 |
| Food and Beverage | $1,491.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $16,263.44 | 2021-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic Vascular, INC. | $10,500.00 | 2020 | |
| Boston Scientific Corporation | $7,500.00 | 2020 | |
| Medtronic, INC. | $5,806.68 | 2021-2025 | Corevalve Evolut R |
| Abiomed | $4,703.95 | 2022-2025 | |
| Pi-Cardia, INC. | $3,000.00 | 2025 | Shortcut |
| Abbott Laboratories | $1,617.13 | 2023-2025 | Portico, Navitor, Optis |
| Terumo Medical Corporation | $350.00 | 2022 | |
| Penumbra, INC. | $260.00 | 2020 | |
| Ancora Heart, INC. | $234.40 | 2022 | |
| Philips North America LLC | $126.44 | 2023-2024 | (Br4) Coronary Undivided |
| Novartis Pharmaceuticals Corporation | $108.78 | 2019 | |
| Ferring Pharmaceuticals INC. | $20.06 | 2023 | Euflexxa |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nilay Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.